We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$46.3B
1-Year Est. Return
43.9%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$27.3B
AUM Growth
-$28.2B
(-51%)
Cap. Flow
-$28.9B
Cap. Flow
% of AUM
-105.88%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
1,354
New
88
Increased
57
Reduced
1,096
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$36.3M |
| 2 |
Paycom
PAYC
|
+$30.3M |
| 3 |
Airbnb
ABNB
|
+$26.2M |
| 4 |
Charles River Laboratories
CRL
|
+$22.6M |
| 5 |
Bio-Techne
TECH
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Amazon
AMZN
|
+$1.15B |
| 3 |
Apple
AAPL
|
+$1.01B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$881M |
| 5 |
Comcast
CMCSA
|
+$482M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.21% |
| 2 | Healthcare | 16.15% |
| 3 | Financials | 15.41% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRDX
976
DELISTED
Surmodics
SRDX
| $294K | ﹤0.01% |
5,294
-5,294
| -50% | -$294K |
|
977
Amkor Technology
AMKR
$13.6B
| $292K | ﹤0.01% |
11,689
-11,689
| -50% | -$298K |
|
978
AquaBounty Technologies
AQB
$5.71M
| $291K | ﹤0.01% |
3,575
-3,575
| -50% | -$335K |
|
979
Gentex
GNTX
$5.09B
| $286K | ﹤0.01% |
8,683
-15,999
| -65% | -$517K |
|
980
Hecla Mining
HL
$11.2B
| $286K | ﹤0.01% |
52,074
-66,990
| -56% | -$417K |
|
981
Herc Holdings
HRI
$5.69B
| $285K | ﹤0.01% |
1,745
-1,745
| -50% | -$221K |
|
982
TD Synnex
SNX
$20.3B
| $282K | ﹤0.01% |
+2,712
| New | +$324K |
|
|
WIRE
983
DELISTED
Encore Wire Corp
WIRE
| $277K | ﹤0.01% |
+2,921
| New | +$240K |
|
|
MDRX
984
DELISTED
Veradigm Inc. Common Stock
MDRX
| $274K | ﹤0.01% |
20,524
-71,664
| -78% | -$1.16M |
|
|
NLSN
985
DELISTED
Nielsen Holdings plc
NLSN
| $274K | ﹤0.01% |
14,312
-31,538
| -69% | -$702K |
|
986
Matador Resources
MTDR
$6.15B
| $273K | ﹤0.01% |
7,168
-7,168
| -50% | -$220K |
|
987
Sensient Technologies
SXT
$5.55B
| $273K | ﹤0.01% |
2,993
-2,993
| -50% | -$262K |
|
|
ISBC
988
DELISTED
Investors Bancorp, Inc.
ISBC
| $272K | ﹤0.01% |
18,011
-1,533,015
| -99% | -$21.4M |
|
989
Brighthouse Financial
BHF
$3.5B
| $270K | ﹤0.01% |
5,977
-5,977
| -50% | -$269K |
|
990
Corcept Therapeutics
CORT
$11.9B
| $270K | ﹤0.01% |
13,718
-13,718
| -50% | -$287K |
|
991
XPO
XPO
$23.6B
| $270K | ﹤0.01% |
5,719
-53,896
| -90% | -$2.7M |
|
992
Under Armour
UAA
$2.58B
| $268K | ﹤0.01% |
13,295
-12,441
| -48% | -$275K |
|
993
Azenta
AZTA
$1.46B
| $267K | ﹤0.01% |
2,608
-2,608
| -50% | -$234K |
|
994
Alcoa
AA
$13.1B
| $264K | ﹤0.01% |
+5,398
| New | +$228K |
|
995
FuelCell Energy
FCEL
$1.58B
| $264K | ﹤0.01% |
1,316
-1,316
| -50% | -$261K |
|
996
American States Water
AWR
$3.46B
| $263K | ﹤0.01% |
3,072
-1,396
| -31% | -$123K |
|
|
OPI
997
DELISTED
Office Properties Income Trust
OPI
| $263K | ﹤0.01% |
10,364
-10,364
| -50% | -$282K |
|
998
ONE Gas
OGS
$5.03B
| $258K | ﹤0.01% |
4,079
-4,079
| -50% | -$291K |
|
|
IVC
999
DELISTED
Invacare Corporation
IVC
| $252K | ﹤0.01% |
+53,021
| New | +$387K |
|
1000
MasTec
MTZ
$21.9B
| $251K | ﹤0.01% |
2,905
-2,905
| -50% | -$276K |
|
Similar funds
LP
TI
KBC Group's Q3 2021 Portfolio in Review
As of Q3 2021, KBC Group held 1,354 positions worth $27.3B, down 51% from $55.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
KBC Group withdrew a net $28.9B in Q3 2021, closing 66 positions and reducing 1,096 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $42.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in DoorDash worth $9.43M.
- KBC Group's largest Q3 2021 buy was DoorDash: 45,764 shares worth $9.43M.
- KBC Group added most to Zscaler in Q3 2021, an estimated $36.3M increase.
- KBC Group's biggest Q3 2021 reduction was Microsoft, cutting an estimated $1.57B.
- KBC Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $42.6M.
- KBC Group's ten largest holdings make up 23% of its $27.3B portfolio in Q3 2021.
- KBC Group opened 88 new positions and closed 66 in Q3 2021.
- KBC Group's portfolio value fell 51% quarter-over-quarter to $27.3B.
Based on KBC Group's 13F filing for Q3 2021, filed 10 Nov 2021.